Clinical Trial Update: Hyaluronic Acid for Hypofractionated Prostate Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hyaluronic acid as an adjunct in hypofractionated radiotherapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN